about
Adenosine-associated delivery systemsPolymeric drug delivery for the treatment of glioblastomaCurrent approaches to enhance CNS delivery of drugs across the brain barriersDrug-triggered and cross-linked self-assembling nanofibrous hydrogels.Gap junction blockers: a potential approach to attenuate morphine withdrawal symptoms.Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumorsTreatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.In Vitro Degradation of an Aromatic Polyanhydride with Enhanced Thermal Properties.Synthesis and characterization of a library of in-situ curing, nonswelling ethoxylated polyol thiol-ene hydrogels for tailorable macromolecule delivery.Nanostructured Pt(NH(3))(4)Cl(2)/SiO(2) for nanomedicine: catalytic degradation of DNA in cancer cellsLocal delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours.Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a reviewTheranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma.Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.Biomaterials for the central nervous systemIntraventricular and intracerebral delivery of anti-epileptic drugs in the kindling model.Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.Polymeric drug delivery systems for localized cancer chemotherapy.Liposomes for brain delivery.Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.Cellular uptake of Nigella sativa oil-PLGA microparticle by PC-12 cell line.Biodegradable implants efficiently deliver combination of paclitaxel and temozolomide to glioma C6 cancer cells in vitro.The Effects of Lactidyl/Glycolidyl Ratio and Molecular Weight of Poly(D,L -Lactide-co-Glycolide) on the Tetracycline Entrapment and Release Kinetics of Drug-Loaded Nanofibers.Nanoengineered drug-releasing Ti wires as an alternative for local delivery of chemotherapeutics in the brainLevels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol).Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment.EMP-induced BBB-disruption enhances drug delivery to glioma and increases treatment efficacy in rats.Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment.Antiepileptic effect of gap-junction blockers in a rat model of refractory focal cortical epilepsy.Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate.Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme.
P2860
Q26785351-F98185F5-1A9C-407C-8A14-4B28B4ABE3D8Q27010046-A532E958-6A58-4CAC-9333-4D2901FBE2FEQ30437835-0D940DA0-3978-421B-A636-64EA2EC36240Q30670908-64CF192E-E182-4267-9FE4-9EFC4E581342Q33586541-DEFC92A9-E925-4B05-8FFD-75566CB72EDBQ34419939-DC09C73D-5516-488A-BF01-ADD2CFD00148Q35251878-D275C7DB-685C-43A3-8D33-69D81140B34DQ35353651-25F87C25-81F1-47D3-B86B-D89AB617560EQ35405498-A57B9C26-5B21-4EE2-838A-61A5F19AAE84Q35547337-DB872705-5D4C-4CD4-9F7F-5A010532F657Q36150422-5D4156A1-6778-4D11-B452-514CF17E2476Q36160994-8F013547-F238-4CAC-8830-26A9DD29C82BQ36297929-5BB25BC6-31E9-41D5-BA41-2B10309FD811Q36378429-699BC57F-D5E5-4E6A-97FE-83857708CE76Q36777653-6A37A805-DAE3-4EA7-855A-52AAE077DD64Q37426994-4D99DFC1-CF53-4A74-AE36-1AE0D1E9386BQ37736273-1B050FDF-1756-4BFF-BBBF-7DD98F1E76B0Q37739481-3CBD2789-8B64-47CF-A27A-588E3361CE7FQ38078421-B25996B0-8CF1-4CAC-8316-9D48A53BAD90Q38857113-45695495-0D1C-4E0C-B09C-AE3C8ECC71ECQ39008600-71DA7453-D900-4DF4-9A89-250EEF256D13Q39098198-31D7A1B8-865F-4099-8551-E49D233606F4Q39561796-463720D6-F37F-4E74-801C-2D49CD774CCEQ42090018-068B9703-C55F-4CFF-8A61-89D5298F48BEQ42914128-D63A4BCF-865D-4C9C-88DE-9D3189C0AC32Q46026100-D57F4457-D0DA-48C5-A1E8-CF3CE12E8CD6Q47653500-E5333F5C-AE4D-459B-B90B-7CB68095F130Q47682175-6B04E63D-8464-40BD-932E-D63DE1896AC7Q48455847-EC76B478-B67D-4306-8ECB-3B8852E1C50DQ48701642-1C179684-6048-4928-8021-D060A37FD16DQ54970083-74254C41-21D9-431A-937C-E0D024115A3B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Local drug delivery to the brain.
@ast
Local drug delivery to the brain.
@en
Local drug delivery to the brain.
@nl
type
label
Local drug delivery to the brain.
@ast
Local drug delivery to the brain.
@en
Local drug delivery to the brain.
@nl
prefLabel
Local drug delivery to the brain.
@ast
Local drug delivery to the brain.
@en
Local drug delivery to the brain.
@nl
P2093
P1476
Local drug delivery to the brain.
@en
P2093
Henry Brem
James Frazier
Paul P Wang
P304
P356
10.1016/S0169-409X(02)00054-6
P407
P577
2002-10-01T00:00:00Z